AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Over the last 12 months, insiders at AxoGen, Inc. have bought $0 and sold $1.07M worth of AxoGen, Inc. stock.
On average, over the past 5 years, insiders at AxoGen, Inc. have bought $188,940 and sold $2.2M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $62,240 was made by Wendell Amy McBride (director) on 2023‑09‑06.
2024-03-21 | Sale | CEO | 39,280 0.091% | $7.68 | $301,670 | +18.90% | ||
2024-03-21 | Sale | Chief Innovation Officer | 4,578 0.0106% | $7.68 | $35,159 | +18.90% | ||
2024-03-21 | Sale | Chief R&D Officer | 6,881 0.0159% | $7.68 | $52,846 | +18.90% | ||
2024-03-21 | Sale | VP Operations | 6,033 0.014% | $7.68 | $46,333 | +18.90% | ||
2024-03-07 | Sale | director | 25,000 0.0581% | $9.00 | $225,000 | -8.76% | ||
2024-03-07 | Sale | VP Operations | 36,310 0.0826% | $8.81 | $319,891 | -8.76% | ||
2023-12-11 | Sale | EVP & Chief Financial Officer | 12,500 0.0291% | $7.50 | $93,809 | +17.24% | ||
2023-09-06 | director | 10,000 0.0235% | $6.22 | $62,240 | +16.26% | |||
2023-08-23 | director | 10,000 0.0234% | $6.56 | $65,600 | +7.44% | |||
2023-08-16 | director | 10,000 0.0252% | $6.11 | $61,100 | +23.36% | |||
2023-06-01 | Sale | director | 41,980 0.0994% | $8.71 | $365,780 | -18.63% | ||
2023-05-23 | Sale | director | 7,468 0.0176% | $9.23 | $68,899 | -21.55% | ||
2023-02-01 | Sale | EVP & Chief Financial Officer | 14,550 0.0348% | $9.36 | $136,188 | -11.25% | ||
2023-01-31 | Sale | EVP & Chief Financial Officer | 14,320 0.0343% | $9.55 | $136,756 | -12.94% | ||
2023-01-30 | Sale | EVP & Chief Financial Officer | 14,111 0.0334% | $9.69 | $136,736 | -15.26% | ||
2023-01-27 | Sale | EVP & Chief Financial Officer | 20,940 0.0495% | $10.16 | $212,750 | -19.29% | ||
2022-11-16 | Sale | EVP & Chief Financial Officer | 10,649 0.027% | $11.88 | $126,510 | -24.25% | ||
2022-11-14 | Sale | director | 13,000 0.0339% | $12.74 | $165,620 | -27.03% | ||
2022-11-08 | Sale | director | 13,000 0.0337% | $12.50 | $162,500 | -25.66% | ||
2022-08-10 | Sale | 8,886 0.0204% | $9.70 | $86,159 | -4.15% |
Zaderej Karen L. | CEO | 1124565 2.5553% | $14.77 | 9 | 8 | +15.63% |
Freitag Gregory Gene | director | 271594 0.6171% | $14.77 | 6 | 12 | +24.07% |
DeVinney Erick Wayne | Chief Innovation Officer | 165661 0.3764% | $14.77 | 0 | 3 | |
MARIANI PETER J | EVP & Chief Financial Officer | 63603 0.1445% | $14.77 | 1 | 9 | +19.13% |
Scopelianos Angelo | Chief R&D Officer | 52999 0.1204% | $14.77 | 0 | 2 | |
Donovan Michael Patrick | VP Operations | 37992 0.0863% | $14.77 | 0 | 10 | |
Essex Woodlands Fund IX, L.P. | 10 percent owner | 3711111 8.4328% | $14.77 | 0 | 1 | |
Flynn James E | 10 percent owner | 3000000 6.8169% | $14.77 | 0 | 6 | |
Mandato Joseph M | director | 1226773 2.7876% | $14.77 | 1 | 4 | +61.29% |
Hopfenspirger Larry | 10 percent owner | 426066 0.9681% | $14.77 | 1 | 0 | |
Gold Mark Stephen | director | 348761 0.7925% | $14.77 | 5 | 1 | +18.2% |
Harper John Frederick | director | 214094 0.4865% | $14.77 | 2 | 0 | +16.33% |
Engels John P | VP | 98425 0.2237% | $14.77 | 1 | 0 | +19.13% |
Wendell Amy McBride | director | 80342 0.1826% | $14.77 | 4 | 0 | <0.0001% |
NEELS GUIDO J | director | 68259 0.1551% | $14.77 | 1 | 1 | |
MCCARREY SHAWN F | SVP Sales | 33057 0.0751% | $14.77 | 3 | 1 | +6.48% |
Hansen David K | VP Finance & Treasurer | 25588 0.0581% | $14.77 | 0 | 1 | |
Johnston Lee Robert Jr | Chief Finacial Officer | 25000 0.0568% | $14.77 | 3 | 0 | +32.93% |
Rudelius Robert James | director | 23273 0.0529% | $14.77 | 3 | 1 | |
Blackford Quentin S. | director | 15535 0.0353% | $14.77 | 2 | 0 | <0.0001% |
Schiaparelli Jill F | SVP, Bus. Strategy&Marketing | 12750 0.029% | $14.77 | 6 | 0 | +14.98% |
Friedman Mark Louis | VP,Regulatory & Quality | 11124 0.0253% | $14.77 | 0 | 2 | |
Burke William P. Mr. | director | 10000 0.0227% | $14.77 | 1 | 0 | |
Billet Isabelle | Chief Strategy and BD Officer | 9496 0.0216% | $14.77 | 1 | 1 | <0.0001% |
MARTINEZ MARIA D. | Chief Human Resources Officer | 2932 0.0067% | $14.77 | 1 | 2 | <0.0001% |
Leach Kevin | Vice President Marketing | 2000 0.0045% | $14.77 | 1 | 0 | +19.13% |
Grooms Jamie Mark | director | 372 0.0008% | $14.77 | 0 | 11 |
Arrowmark Colorado Holdings Llc | $38.14M | 10.82 | 4.73M | -8.26% | -$3.43M | 0.1 | |
BlackRock | $26.08M | 7.4 | 3.23M | -3.31% | -$892,267.67 | <0.01 | |
Morgan Stanley | $25.67M | 7.28 | 3.18M | +3.18% | +$791,997.89 | <0.01 | |
Soleus Capital Management, L.P. | $25.06M | 7.11 | 3.11M | +19.65% | +$4.12M | 0.1 | |
The Vanguard Group | $19.46M | 5.52 | 2.41M | -2.19% | -$436,530.51 | <0.0001 | |
Perceptive Advisors | $12.54M | 3.56 | 1.55M | +92.23% | +$6.02M | 0.01 | |
Millennium Management LLC | $10.62M | 3.01 | 1.32M | -11.59% | -$1.39M | 0.01 | |
DAFNA Capital Management, LLC | $7.55M | 2.14 | 935,894 | 0% | +$0 | 0.18 | |
Geode Capital Management | $7.51M | 2.13 | 930,810 | +3.85% | +$278,245.86 | <0.01 | |
State Street | $6.45M | 1.83 | 799,051 | +0.88% | +$56,199.48 | <0.0001 | |
Silvercrest Asset Management Group Inc | $6.38M | 1.81 | 790,647 | +4.55% | +$277,599.92 | 0.04 | |
Tocqueville Asset Management | $6.21M | 1.76 | 769,900 | 0% | +$0 | 0.1 | |
First Light Asset Management | $6.18M | 1.75 | 765,886 | +177% | +$3.95M | 0.52 | |
Dimensional Fund Advisors | $5.76M | 1.63 | 714,247 | +23.3% | +$1.09M | <0.01 | |
Prudential Financial | $5.28M | 1.5 | 654,585 | +367.28% | +$4.15M | 0.01 | |
D. E. Shaw & Co. | $4.89M | 1.39 | 606,555 | -0.73% | -$35,774.31 | 0.01 | |
Deutsche Bank | $4.68M | 1.33 | 579,376 | +0.13% | +$5,939.52 | <0.01 | |
Bank of America | $3.78M | 1.07 | 468,435 | -10.21% | -$429,969.55 | <0.0001 | |
Northern Trust | $3.05M | 0.86 | 377,761 | -1.19% | -$36,565.17 | <0.0001 | |
Panagora | $3.01M | 0.85 | 373,237 | +125.57% | +$1.68M | 0.02 | |
Nuveen | $2.85M | 0.81 | 353,136 | 0% | +$0 | <0.01 | |
Charles Schwab | $2.8M | 0.79 | 346,953 | +4.72% | +$126,214.81 | <0.01 | |
Perkins Capital Management Inc | $2.4M | 0.68 | 297,949 | -0.56% | -$13,442.11 | 2.09 | |
Kennedy Capital Management Inc | $2.38M | 0.68 | 294,788 | -1.48% | -$35,620.98 | 0.05 | |
Oberweis Asset Management Inc | $2.31M | 0.66 | 286,400 | New | +$2.31M | 0.17 | |
Ameriprise Financial | $2.23M | 0.63 | 276,645 | -1.92% | -$43,594.12 | <0.01 | |
Kent Lake Capital LLC | $1.62M | 0.46 | 200,348 | New | +$1.62M | 0.73 | |
Goldman Sachs | $1.55M | 0.44 | 191,746 | -62.34% | -$2.56M | <0.0001 | |
Connor Clark & Lunn Investment Management Ltd | $1.55M | 0.44 | 192,001 | +25.67% | +$316,505.39 | <0.01 | |
Birchview Capital Lp | $1.4M | 0.4 | 173,000 | 0% | +$0 | 0.08 | |
Engineers Gate Manager Lp | $1.3M | 0.37 | 160,819 | +9.38% | +$111,325.62 | 0.03 | |
Rice Hall James & Associates, LLC | $1.24M | 0.35 | 153,174 | New | +$1.24M | 0.07 | |
BNY Mellon | $1.19M | 0.34 | 147,094 | -5.36% | -$67,215.05 | <0.0001 | |
Ubs Oconnor Llc | $1.11M | 0.32 | 137,575 | 0% | +$0 | 0.05 | |
Legal & General | $1.04M | 0.3 | 129,302 | +24.2% | +$203,291.34 | <0.0001 | |
Cubist Systematic Strategies | $962,154.00 | 0.27 | 119,226 | +8.85% | +$78,246.74 | 0.01 | |
WHITE PINE CAPITAL, LLC | $712,427.00 | 0.25 | 111,143 | +3.17% | +$21,858.11 | 0.27 | |
Exchange Traded Concepts, LLC | $860,617.00 | 0.24 | 106,644 | +33.53% | +$216,122.65 | 0.02 | |
Divisadero Street Capital Management Lp | $806,758.00 | 0.23 | 99,970 | +117.47% | +$435,788.12 | 0.19 | |
Raymond James Financial Services Advisors Inc | $748,573.00 | 0.21 | 92,760 | +0.54% | +$4,035.00 | <0.01 | |
Renaissance Technologies | $707,000.00 | 0.2 | 87,600 | -19.34% | -$169,486.30 | <0.01 | |
Keeley Teton Advisors Llc | $683,731.00 | 0.19 | 84,725 | 0% | +$0 | 0.09 | |
Franklin Templeton Investments | $526,463.00 | 0.15 | 65,237 | New | +$526,463.00 | <0.0001 | |
M&T Bank | $505,954.00 | 0.14 | 62,690 | +10.41% | +$47,698.01 | <0.01 | |
Assenagon Asset Management S.A. | $500,243.00 | 0.14 | 61,988 | 0% | +$0 | <0.01 | |
RhumbLine Advisers | $442,041.00 | 0.13 | 54,777 | +3.11% | +$13,315.22 | <0.0001 | |
Wells Fargo | $405,800.00 | 0.12 | 50,285 | +25.57% | +$82,644.88 | <0.0001 | |
AllianceBernstein | $385,665.00 | 0.11 | 47,790 | 0% | +$0 | <0.0001 | |
American Century Investments | $377,797.00 | 0.11 | 46,815 | +176.98% | +$241,397.88 | <0.0001 | |
Roubaix Capital, LLC | $350,577.00 | 0.1 | 43,442 | New | +$350,577.00 | 0.22 |